This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Compared to Estimates, Sweetgreen (SG) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Sweetgreen (SG) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Noodles & Co. (NDLS) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Noodles & Co. (NDLS) delivered earnings and revenue surprises of 35% and 0.63%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
5 Critical Earnings Charts for This Week
by Tracey Ryniec
These are the 5 must-see earnings charts for this week.
Zacks Market Edge Highlights: Microsoft, NVIDIA, Sweetgreen, Constellation Energy and Rivian Automotive
by Zacks Equity Research
Microsoft, NVIDIA, Sweetgreen, Constellation Energy and Rivian Automotive are part of the Zacks Market Edge article.
What Are GenZ's Favorite Stocks?
by Tracey Ryniec
GenZ is starting to invest. What they are buying may surprise you.
Sweetgreen, Inc. (SG) Soars 7.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Sweetgreen, Inc. (SG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Sweetgreen (SG) Q4 Earnings Miss Estimates, Revenues Top
by Zacks Equity Research
Sweetgreen's (SG) fiscal fourth-quarter performance benefits from menu innovation, supply chain advancements and cutting-edge technology integration.
Sweetgreen, Inc. (SG) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Sweetgreen, Inc. (SG) delivered earnings and revenue surprises of -4.35% and 1.36%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Carrols Restaurant's (TAST) in Q4 Earnings?
by Zacks Equity Research
Carrols Restaurant's (BJRI) fourth-quarter performance is likely to have gained from strong Burger King Performance, digital business growth and new product launches.
Factors Setting the Tone for Beacon Roofing's (BECN) Q4 Earnings
by Zacks Equity Research
Beacon Roofing's (BECN) Q4 results are likely to reflect more demand from the non-discretionary repair and re-roofing market, investments in greenfields and acquisitions.
Sweetgreen, Inc. (SG) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
Sweetgreen, Inc. (SG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wingstop (WING) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Wingstop's (WING) fourth-quarter top line is likely to have benefited from menu innovation, new restaurant openings and an expanded delivery platform.
Here's What to Expect From Jack in the Box's (JACK) Q1 Earnings
by Zacks Equity Research
Jack in the Box's (JACK) first-quarter fiscal 2024 results are likely to reflect the impacts of tepid restaurant sales and an inflationary cost environment.
Texas Roadhouse (TXRH) Surpasses Q4 Earnings Estimates
by Zacks Equity Research
Texas Roadhouse (TXRH) delivered earnings and revenue surprises of 0.93% and 0.18%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Sweetgreen (SG) Expands Domestic Footprint With New Location
by Zacks Equity Research
Sweetgreen (SG) marks its Pacific Northwest debut in Seattle, expanding its domestic footprint.
Will Sweetgreen, Inc. (SG) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Sweetgreen, Inc. (SG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sweetgreen, Inc. (SG) Upgraded to Buy: Here's Why
by Zacks Equity Research
Sweetgreen, Inc. (SG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Sweetgreen, Inc. (SG) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Sweetgreen, Inc. (SG) delivered earnings and revenue surprises of -5.26% and 2.22%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Starbucks (SBUX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Starbucks (SBUX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sweetgreen, Inc. (SG) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
by Zacks Equity Research
Sweetgreen, Inc. (SG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sweetgreen (SG) Boosts Presence With New Restaurant in Milwaukee
by Zacks Equity Research
Sweetgreen (SG) continues to expand its domestic footprint, unveiling its first Wisconsin restaurant in Milwaukee.
Sweetgreen, Inc. (SG) Moves 15.5% Higher: Will This Strength Last?
by Zacks Equity Research
Sweetgreen, Inc. (SG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Wall Street Analysts Believe Sweetgreen, Inc. (SG) Could Rally 49.12%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for Sweetgreen, Inc. (SG) points to a 49.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks.com featured highlights Sweetgreen, Adaptimmune Therapeutics, Owl Rock Capital, MACOM Technology Solutions and Equity Commonwealth
by Zacks Equity Research
Sweetgreen, Adaptimmune Therapeutics, Owl Rock Capital, MACOM Technology Solutions and Equity Commonwealth have been highlighted in this Screen of The Week article.
Sweetgreen, Inc. (SG) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Sweetgreen, Inc. (SG) delivered earnings and revenue surprises of 19.44% and 0.41%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?